Intravenous cyclophophamide in steroid-resistant nephrotic syndrome

Pediatric Nephrology

Volumn 18, Issue 4, 2003, Pages 351-356

  Bajpai, Anurag ^a   Bagga, Arvind ^a   Hari, Pankaj ^a   Dinda, Amit ^a   Srivastava, Rajendra N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Focal segmental glomerulosclerosis; Minimal change disease; Pulse cyclophophamide; Pulse dexamethasone

Indexed keywords

ALBUMIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; PREDNISOLONE; ALKYLATING AGENT; CHOLESTEROL; SERUM ALBUMIN;

AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; CELLULITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HAIR DISEASE; HEMOGLOBINOPATHY; HISTOPATHOLOGY; HUMAN; INFECTION; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; LEUKOPENIA; LONG TERM CARE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NAIL PIGMENTATION; NEPHROTIC SYNDROME; NEUTROPENIA; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; REMISSION; THROMBOCYTOPENIA; VOMITING; ADOLESCENT; BLOOD; CLINICAL TRIAL; DRUG RESISTANCE; INFANT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; METABOLISM; PATHOLOGY; PRESCHOOL CHILD; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ALKYLATING AGENTS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CYCLOPHOSPHAMIDE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; KIDNEY; MALE; NEPHROTIC SYNDROME; PROSPECTIVE STUDIES; RECURRENCE; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 0038159557     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1095-3     Document Type: Article

References (19)

1. Niaudet P (1999) Steroid resistant idiopathic nephrotic syndrome. In: Barratt TM, Avner ED, Harmon WE (eds) Pediatric Nephrology, 4th edn. Williams and Wilkins, Baltimore, pp 749-764
2. Tune BM, Lieberman E, Mendoza SA (1996) Steroid resistant nephrotic focal segmental glomerulosclerosis: a treatable disease. Pediatr Nephrol 10:772-778
3. Guillot AP, Kim MS (1993) Pulse steroid therapy does not alter the course of focal segmental glomerulosclerosis (abstract). J Am Soc Nephrol 4:276
4. Niaudet P, Fuchshuber A, Gagnadoux MF, Habib R, Broyer M (1997) Cyclosporine in the therapy of steroid-resistant idiopathic nephrotic syndrome. Kidney Int [Suppl] 58:S85-S90
5. Tarshish P, Tobin JN, Bernstein J, Edelman CM Jr (1996) Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis: a report of the International Study of Kidney Diseases in Children. Pediatr Nephrol 10:590-593
6. Elhence R, Gulati S, Kher V, Gupta A, Sharma RK (1994) Intravenous pulse cyclophosphamide - a new regimen for steroid resistant minimal change nephrotic syndrome. Pediatr Nephrol 8:1-3
7. Rennert WP, Kala VK, Jacobs D, Goetsch S, Verhaart S (1999) Pulse cyclophosphamide for steroid-resistant focal and segmental glomerulosclerosis. Pediatr Nephrol 13:113-116
8. Adhikari M, Bhimma R, Coovadia HM (1997) Intensive pulse therapies for focal glomerulosclerosis in South African children. Pediatr Nephrol 11:423-428
9. Gulati S, Kher V (2000) Intravenous cyclophosphamide - a new regimen for steroid resistant focal segmental glomerulosclerosis. Indian Pediatr 37:141-148
10. Groot K de, Adu D, Savage COS (2001) The value of pulse cyclophosphamide in ANCA-associated vasculitis; meta-analysis and critical review. Nephrol Dial Transplant 16:2018-2027
11. Hari P, Bagga A, Jindal N, Srivastava RN (2001) Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Pediatr Nephrol 16:901-905
12. Indian Pediatric Nephrology Group, Indian Academy of Pediatrics (2001) Consensus statement on management of steroid sensitive nephrotic syndrome. Indian Pediatr 38:975-986
13. Srivastava RN, Mayekar G, Anand R, Choudhry VP, Ghai OP, Tandon HD (1975) Nephrotic syndrome in Indian children. Arch Dis Child 50:626-630
14. Schwartz GJ, Haycock GB, Edelman CM, Spitzer A (1976) A simple measure of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263
15. Ortmann RA, Klippel JH (2000) Update on cyclophosphamide for systemic lupus erythematosus. Rheum Dis Clin North Am 26:363-375
16. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769-776
17. Alexopoulos E, Stangou M, Papagianni A, Pantzaki A, Papadimitriou M (2000) Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 15:1348-1356
18. Gulati S, Pokhariyal S, Sharma RK, Elhence R, Kher V, Pandey CM, Gupta A (2001) Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome. Nephrol Dial Transplant 16:2013-2022
19. Martin F, Lauwerys B, Lefebvre C, Devogelaer JP, Houssiau FA (1997) Side-effects of intravenous cyclophosphamide pulse therapy. Lupus 6:254-257